An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus–cell fusion
- 1 May 2005
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 86 (5) , 1499-1507
- https://doi.org/10.1099/vir.0.80414-0
Abstract
Evidence has been presented which shows that part of the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 (HIV-1) contains a neutralization epitope and is thus exposed on the external surface of the virion. Here, SAR1, a monoclonal antibody, which was stimulated by immunization with a plant virus expressing 60 copies of the GERDRDR sequence from the exposed gp41 tail, and has an unusual pattern of neutralization activity, giving little or no neutralization of free virions, but effecting modest post-attachment neutralization (PAN) of virus bound to target cells was investigated. Here, the properties of PAN were investigated. It was found that PAN could be mediated at 4 or 20 °C, but that at 20 °C maximum PAN required virus–cell complexes to be incubated for 3 h before addition of antibody. Further PAN appeared stable at 20 °C and could be mediated for at least 5 h at this temperature. In contrast, when virus–cell complexes formed at 20 °C but then shifted to 37 °C for various times before addition of SAR1, PAN was maximal after just 10 min, and was lost after 30 min incubation. Thus, PAN at 37 °C is transient and temperature-dependent. Since this scenario recalled the temperature requirements of virus–cell fusion, fusion of HIV-1-infected and non-infected cells was investigated, and it was found that SAR1 inhibited this process by up to 75 %, in a dose-dependent manner. However, antibodies to adjacent epitopes did not inhibit fusion. These data confirm the external location of the SAR1 epitope, implicate the gp41 C-terminal tail in the HIV-1 fusion process for the first time, and suggest that SAR1 mediates PAN by inhibiting virus-mediated fusion.Keywords
This publication has 77 references indexed in Scilit:
- Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusionJournal of General Virology, 2005
- Immunogenic and Antigenic Dominance of a Nonneutralizing Epitope over a Highly Conserved Neutralizing Epitope in the gp41 Envelope Glycoprotein of Human Immunodeficiency Virus Type 1: Its Deletion Leads to a Strong Neutralizing ResponseVirology, 2000
- The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.Journal of General Virology, 1998
- Three-dimensional solution structure of the 44kDa ectodomain of SIV gp41The EMBO Journal, 1998
- Core Structure of gp41 from the HIV Envelope GlycoproteinPublished by Elsevier ,1997
- Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1Journal of General Virology, 1996
- Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp120: identification of a very early fusion-independent event as a neutralization targetJournal of General Virology, 1996
- Epitope Mapping and Topology of Baculovirus-Expressed HIV-1 gp160 Determined with a Panel of Murine Monoclonal AntibodiesAIDS Research and Human Retroviruses, 1994
- Synergistic Inhibition of HIV-1 Envelope-Mediated Cell Fusion by CD4-Based Molecules in Combination with Antibodies to gp120 or gp41AIDS Research and Human Retroviruses, 1993
- Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.Proceedings of the National Academy of Sciences, 1992